Therapeutic Asset Ratings
831 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DIPHTHERIA TOXOID ADSORBED
Primary Peritoneal Carcinosarcoma
Mayo Clinic
P2
CCC
(53)
DIPHTHERIA TOXOID ADSORBED
Primary Peritoneal Endometrioid Adenocarcinoma
Mayo Clinic
P2
CCC
(53)
Durvalumab
Richter Transformation
Mayo Clinic
P2
CCC
(53)
Eloxatin
Clonal Cytopenia of Undetermined Significance
Mayo Clinic
P2
CCC
(53)
Epirubicin
High Grade Astrocytic Tumor
Mayo Clinic
P2
CCC
(53)
Epirubicin
Intravascular Large B-Cell Lymphoma
Mayo Clinic
P2
CCC
(53)
Epirubicin
Progressive Astrocytoma, IDH-Mutant, Grade 4
Mayo Clinic
P2
CCC
(53)
Epirubicin
Recurrent ALK Positive Large B-Cell Lymphoma
Mayo Clinic
P2
CCC
(53)
Epirubicin
Recurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
Mayo Clinic
P2
CCC
(53)
Epirubicin
Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Mayo Clinic
P2
CCC
(53)
Epirubicin
Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Mayo Clinic
P2
CCC
(53)
Epirubicin
Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Mayo Clinic
P2
CCC
(53)
Epirubicin
Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Mayo Clinic
P2
CCC
(53)
Epirubicin
Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Mayo Clinic
P2
CCC
(53)
Epirubicin
Resectable Astrocytoma
Mayo Clinic
P2
CCC
(53)
ER-176
Demyelinating Disease
Mayo Clinic
P2
CCC
(53)
ETOPOSIDE
Clonal Cytopenia of Undetermined Significance
Mayo Clinic
P2
CCC
(53)
Fenofibrate
Biliary Strictures
Mayo Clinic
P2
CCC
(53)
Fenofibrate
Disease Related To Solid Organ Transplantation
Mayo Clinic
P2
CCC
(53)
Fianlimab
Lung Cancer
Mayo Clinic
P2
CCC
(53)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Plasma Cell Myeloma
Mayo Clinic
P2
CCC
(53)
FLORTAUCIPIR
Dementia, Mild
Mayo Clinic
P2
CCC
(53)
FLUDEOXYGLUCOSE
Richter Syndrome
Mayo Clinic
P2
CCC
(53)
Fremanezumab
Cerebral Arteriopathy, Autosomal Dominant, With Subcortical Infarcts And Leukoencephalopathy, Type 1
Mayo Clinic
P2
CCC
(53)
gi-102
IDH-Wildtype Glioblastoma
Mayo Clinic
P2
CCC
(53)
Showing 376 to 400 of 831 assets
Previous
Page 16 of 34
Next